MedPage Today August 20, 2025
Jennifer Henderson

Disasters pose risks of disruptions to facilities active in all aspects of the supply chain

Key Takeaways

  • Nearly two-thirds of the active U.S. drug production facilities over the last 6 years resided in counties where a climate-related disaster was declared.
  • These included facilities that manufacture, analyze, and package drug products.
  • Hurricanes were the most common event leading to a disaster declaration in counties with drug facilities.

Most of the nation’s drug manufacturing plants reside in the path of hurricanes, wildfires, and other natural disasters, posing risks to the supply chain, a national assessment indicated.

Among nearly 11,000 active U.S. facilities from 2019 to 2024, 62.8% were located in counties where at least one climate-related disaster was declared, reported...

Today's Sponsors

Venturous
ZeOmega

Today's Sponsor

Venturous

 
Topics: Biotechnology, Pharma, Pharma / Biotech, Supply Chain, Technology
283: A candid conversation: Physicians on the front lines of GLP‑1 care
BigHat, Revvity Collaborate with Eli Lilly, Immunai Signs Agreement with Bristol Myers Squibb, SandboxAQ Launches New AI Model
Q&A: New PQA Resource Highlights 40 Projects Targeting Social Determinants of Health
NVIDIA and Lilly Announce Co-Innovation AI Lab to Accelerate Drug Discovery
Data Visualization is Broken in Biotech: Q&A with Sunitha Venkat

Share Article